226 related articles for article (PubMed ID: 1538151)
1. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group.
Whitley RJ; Gnann JW; Hinthorn D; Liu C; Pollard RB; Hayden F; Mertz GJ; Oxman M; Soong SJ
J Infect Dis; 1992 Mar; 165(3):450-5. PubMed ID: 1538151
[TBL] [Abstract][Full Text] [Related]
2. Antiviral treatment in chickenpox and herpes zoster.
Huff JC
J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):204-6. PubMed ID: 3339143
[TBL] [Abstract][Full Text] [Related]
3. Comparative trial of acyclovir and vidarabine in disseminated varicella-zoster virus infections in immunocompromised patients.
Vildé JL; Bricaire F; Leport C; Renaudie M; Brun-Vézinet F
J Med Virol; 1986 Oct; 20(2):127-34. PubMed ID: 3534140
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.
Balfour HH; McMonigal KA; Bean B
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():169-79. PubMed ID: 6313596
[TBL] [Abstract][Full Text] [Related]
5. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine.
Shepp DH; Dandliker PS; Meyers JD
N Engl J Med; 1986 Jan; 314(4):208-12. PubMed ID: 3001523
[TBL] [Abstract][Full Text] [Related]
6. Treatment of disseminated herpes zoster in six severely immunocompromised patients: acyclovir and vidarabine.
Nagafuchi S; Moriyama K; Takamatsu Y; Hayashi S; Niho Y; Takenaka A; Minagawa H; Mori R
Jpn J Med; 1989; 28(1):100-4. PubMed ID: 2724639
[TBL] [Abstract][Full Text] [Related]
7. Natural history and treatment of varicella-zoster in high-risk populations.
Gnann JW; Whitley RJ
J Hosp Infect; 1991 Jun; 18 Suppl A():317-29. PubMed ID: 1679798
[TBL] [Abstract][Full Text] [Related]
8. Comparison of acyclovir and vidarabine in immunocompromised children with varicella-zoster virus infection.
Kunitomi T; Akazai A; Ikeda M; Oda M; Kodani N
Acta Paediatr Jpn; 1989 Dec; 31(6):702-5. PubMed ID: 2516397
[TBL] [Abstract][Full Text] [Related]
9. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches to varicella-zoster virus infections.
Whitley RJ
J Infect Dis; 1992 Aug; 166 Suppl 1():S51-7. PubMed ID: 1378081
[TBL] [Abstract][Full Text] [Related]
11. Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.
Shepp DH; Dandliker PS; Meyers JD
Am J Med; 1988 Aug; 85(2A):96-8. PubMed ID: 3044102
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.
Wood MJ; Johnson RW; McKendrick MW; Taylor J; Mandal BK; Crooks J
N Engl J Med; 1994 Mar; 330(13):896-900. PubMed ID: 8114860
[TBL] [Abstract][Full Text] [Related]
13. SIADH during disseminated Herpes varicella-zoster infections: relationship to vidarabine therapy.
Semel JD; McNerney JJ
Am J Med Sci; 1986 Feb; 291(2):115-8. PubMed ID: 3946467
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir halts progression of herpes zoster in immunocompromised patients.
Balfour HH; Bean B; Laskin OL; Ambinder RF; Meyers JD; Wade JC; Zaia JA; Aeppli D; Kirk LE; Segreti AC; Keeney RE
N Engl J Med; 1983 Jun; 308(24):1448-53. PubMed ID: 6343861
[TBL] [Abstract][Full Text] [Related]
15. Acyclovir treatment of disseminated varicella in childhood malignant neoplasms.
Shulman ST
Am J Dis Child; 1985 Feb; 139(2):137-40. PubMed ID: 3856382
[TBL] [Abstract][Full Text] [Related]
16. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management.
Balfour HH
Am J Med; 1988 Aug; 85(2A):68-73. PubMed ID: 3044096
[TBL] [Abstract][Full Text] [Related]
17. Successful combination therapy with acyclovir and vidarabine for disseminated varicella zoster virus infection with retinal involvement in a patient with B-cell lymphoma and adult T-cell leukemia.
Moriyama K; Asano Y; Fujimoto K; Okamura T; Shibuya T; Harada M; Niho Y
Am J Med; 1988 Dec; 85(6):885-6. PubMed ID: 3264113
[No Abstract] [Full Text] [Related]
18. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.
Whitley R; Arvin A; Prober C; Burchett S; Corey L; Powell D; Plotkin S; Starr S; Alford C; Connor J
N Engl J Med; 1991 Feb; 324(7):444-9. PubMed ID: 1988829
[TBL] [Abstract][Full Text] [Related]
19. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group.
Gnann JW; Crumpacker CS; Lalezari JP; Smith JA; Tyring SK; Baum KF; Borucki MJ; Joseph WP; Mertz GJ; Steigbigel RT; Cloud GA; Soong SJ; Sherrill LC; DeHertogh DA; Whitley RJ
Antimicrob Agents Chemother; 1998 May; 42(5):1139-45. PubMed ID: 9593141
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.
Tyring S; Belanger R; Bezwoda W; Ljungman P; Boon R; Saltzman RL;
Cancer Invest; 2001; 19(1):13-22. PubMed ID: 11291551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
